pyrazines has been researched along with Hemorrhagic Fevers, Viral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, KW; Gantla, VR; Gowen, BB; Henkel, G; Hickerson, BT; McCormack, K; Naik, S; Wandersee, L; Westover, JB | 1 |
| de Lamballerie, X; Extramiana, F; Malvy, D; Mentre, F; Taburet, AM | 1 |
| De Clercq, E | 1 |
| Furuta, Y; Gowen, BB; Hagloch, J; Hall, JO; Sefing, EJ; Smee, DF; Westover, JB | 1 |
| Bailey, KW; Bray, M; Dagley, A; Downs, B; Furuta, Y; Gowen, BB; Jung, KH; Sefing, EJ; Smee, DF; Van Wettere, AJ; Wandersee, L; Westover, JB | 1 |
| Bailey, KW; Furuta, Y; Gowen, BB; Hall, JO; Jung, KH; Morrey, JD; Smee, DF; Stevens, JR; Wong, MH | 1 |
1 review(s) available for pyrazines and Hemorrhagic Fevers, Viral
| Article | Year |
|---|---|
New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections.
Topics: Adenine; Adenosine; Alanine; Amides; Antiviral Agents; Base Pairing; Ebolavirus; Guanine; Hemorrhagic Fevers, Viral; Humans; Nucleotides; Phosphoric Acids; Pyrazines; Triazines | 2019 |
5 other study(ies) available for pyrazines and Hemorrhagic Fevers, Viral
| Article | Year |
|---|---|
Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir.
Topics: Amides; Animals; Anti-Retroviral Agents; Arenaviridae; Guinea Pigs; Hemorrhagic Fever, American; Hemorrhagic Fevers, Viral; Junin virus; Mice; Pyrazines | 2022 |
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.
Topics: Amides; Antiviral Agents; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Heart Conduction System; Hemorrhagic Fevers, Viral; Humans; Pyrazines | 2020 |
Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.
Topics: Amides; Animal Structures; Animals; Antiviral Agents; Disease Models, Animal; Female; Hemorrhagic Fevers, Viral; Mesocricetus; Plasma; Pyrazines | 2015 |
Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
Topics: Amides; Animals; Antiviral Agents; Arenavirus; Chlorocebus aethiops; Cricetinae; Dengue Virus; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, American; Hemorrhagic Fever, Ebola; Hemorrhagic Fevers, Viral; Junin virus; Male; Mesocricetus; Mice; Orthohantavirus; Pyrazines; Ribavirin; RNA Viruses; Vero Cells | 2016 |
Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
Topics: Absorption; Administration, Oral; Alanine Transaminase; Amides; Animals; Arenaviridae Infections; Aspartate Aminotransferases; Cricetinae; Disease Models, Animal; Disease Progression; Female; Hemorrhagic Fevers, Viral; Interferon Type I; Liver Diseases; Mesocricetus; Pichinde virus; Pyrazines; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load | 2008 |